Standard
Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. / Astrup, Arne; Carraro, Romina; Finer, N; Harper, A; Kunesova, M; Lean, M E J; Niskanen, L; Rasmussen, M F; Rissanen, A; Rössner, S; Savolainen, M J; Van Gaal, L.
In:
International Journal of Obesity, Vol. 37, No. 2, 2013, p. 322.
Research output: Contribution to journal › Comment/debate › Research
Harvard
Astrup, A, Carraro, R, Finer, N, Harper, A, Kunesova, M, Lean, MEJ, Niskanen, L, Rasmussen, MF, Rissanen, A, Rössner, S, Savolainen, MJ & Van Gaal, L 2013, '
Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide',
International Journal of Obesity, vol. 37, no. 2, pp. 322.
https://doi.org/10.1038/ijo.2012.192APA
Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E. J., Niskanen, L., Rasmussen, M. F., Rissanen, A., Rössner, S., Savolainen, M. J., & Van Gaal, L. (2013).
Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.
International Journal of Obesity,
37(2), 322.
https://doi.org/10.1038/ijo.2012.192Vancouver
Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean MEJ et al.
Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.
International Journal of Obesity. 2013;37(2):322.
https://doi.org/10.1038/ijo.2012.192Author
Astrup, Arne ; Carraro, Romina ; Finer, N ; Harper, A ; Kunesova, M ; Lean, M E J ; Niskanen, L ; Rasmussen, M F ; Rissanen, A ; Rössner, S ; Savolainen, M J ; Van Gaal, L. / Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. In: International Journal of Obesity. 2013 ; Vol. 37, No. 2. pp. 322.
Bibtex
@article{ecfbb1c675ca4a1993387dc354a97855,
title = "Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide",
author = "Arne Astrup and Romina Carraro and N Finer and A Harper and M Kunesova and Lean, {M E J} and L Niskanen and Rasmussen, {M F} and A Rissanen and S R{\"o}ssner and Savolainen, {M J} and {Van Gaal}, L",
note = "CURIS 2013 NEXS 057",
year = "2013",
doi = "10.1038/ijo.2012.192",
language = "English",
volume = "37",
pages = "322",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "nature publishing group",
number = "2",
}
RIS
TY - JOUR
T1 - Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
AU - Astrup, Arne
AU - Carraro, Romina
AU - Finer, N
AU - Harper, A
AU - Kunesova, M
AU - Lean, M E J
AU - Niskanen, L
AU - Rasmussen, M F
AU - Rissanen, A
AU - Rössner, S
AU - Savolainen, M J
AU - Van Gaal, L
N1 - CURIS 2013 NEXS 057
PY - 2013
Y1 - 2013
U2 - 10.1038/ijo.2012.192
DO - 10.1038/ijo.2012.192
M3 - Comment/debate
C2 - 23399800
VL - 37
SP - 322
JO - International Journal of Obesity
JF - International Journal of Obesity
SN - 0307-0565
IS - 2
ER -
